Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Severe fever with thrombocytopenia syndrome virus (SFTSV) presents an emerging public threat due to its high mortality rate and ever-expanding geographic distribution. However, characterization of SFTSV infection pathogenesis and immunological impact at single-cell level remains underexplored. Here, we employ single-cell transcriptome-wide sequencing in peripheral blood mononuclear cells (PBMCs) from hospitalized SFTSV-infected patients to map the immune landscape across acute and convalescent stages of infection. The results reveal significant alterations in immune cell compositions, along with profound disruption in intercellular crosstalk. B cells and neutrophils appear to be the primary target for SFTSV infection besides monocytes, as evidenced by heightened virus-related pathways in these two cell types during the acute phase. In addition, SFTSV infection induces a substantial inflammatory response, which were prominently reflected in monocytes and neutrophils. These data illustrate the complex immune remodeling and inflammatory cascades triggered by SFTSV, with a particular focus on its effects on B cells and neutrophils, bringing novel insights into future therapeutic developments.

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmv.70354DOI Listing

Publication Analysis

Top Keywords

sftsv infection
16
cells neutrophils
12
sftsv
6
infection
5
single-cell atlas
4
atlas revealed
4
revealed altered
4
cells
4
altered cells
4
neutrophils
4

Similar Publications

Background: Severe fever with thrombocytopenia syndrome virus (SFTSV) is a highly pathogenic bunyavirus with a high case-fatality ratio for which there is no approved vaccine. Studies have assessed different vaccine technologies. However, few studies have yet assessed the immunogenicity of heterologous prime-boost regimens.

View Article and Find Full Text PDF

Interferon-stimulated gene screening identifies CCND3 as a host restriction factor against emerging high-pathogenic bandaviruses.

Nat Commun

August 2025

State Key Laboratory of Virology and Biosafety and National Virus Resource Center, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.

Severe fever with thrombocytopenia syndrome virus (SFTSV) is a representative high-pathogenic bandavirus (Bandavirus genus, Phenuiviridae family). Inducible expression of interferon-stimulated genes (ISGs) is the foundation of host antiviral defense; however, their roles in bandavirus infection remain elusive. Here, we identify over 200 ISGs potentially inhibiting or promoting bandaviral replication.

View Article and Find Full Text PDF

Current status of severe fever with thrombocytopenia syndrome in China (Review).

Int J Mol Med

November 2025

Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, Henan 450001, P.R. China.

Severe fever with thrombocytopenia syndrome (SFTS) is a newly emerging tick‑borne infectious disease caused by the novel Bunyavirus/SFTS virus (SFTSV). The clinical manifestations mainly include fever, thrombocytopenia and multi‑organ dysfunction, with a fatality rate as high as 30%. Since its first report in China in 2009, cases have subsequently emerged in multiple countries across East and Southeast Asia.

View Article and Find Full Text PDF

Severe fever with thrombocytopenia syndrome (SFTS) is a significant public health concern caused by SFTS virus (SFTSV), a tick-borne RNA virus. Previous studies have identified DC-SIGN and related C-type lectins as receptors of SFTSV infection in specific cell populations. Our genome-wide CRISPR activation screening identified AXL, a receptor tyrosine kinase, as a novel entry receptor for SFTSV.

View Article and Find Full Text PDF

The mRNA vaccine encoding Gc protein confers complete protection against severe fever with thrombocytopaenia syndrome virus.

Vaccine

August 2025

State Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China; Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China; University of Chinese Academy of Sciences, Beijing, China.

Severe fever with thrombocytopaenia syndrome virus (SFTSV), an emerging tick-borne pathogen, causes haemorrhagic fever in infected patients and is associated with a high mortality rate in humans. The imperative need for vaccines against this lethal virus is underscored by a lack of effective preventive measures. The results of this study yield notable advancements: the successful development of an SFTSV mRNA vaccine encoding the glycoprotein C (Gc) gene, achieving N-linked glycosylation in the expressed protein.

View Article and Find Full Text PDF